At Moehs Group, we remain committed to innovation as a fundamental value to continue growing. For this reason, over the last two years, we have invested more than 20 million euros in order to continue being a reference in the manufacture of active pharmaceutical ingredients. More details about the investments in the video:
At Moehs we adapt to all social and environmental circumstances. For this reason, we have revolutionized our processes by adapting a new digitalization system, in particular quality control and documentation. Our data integrity is now technologically excellent. Thank you Marqués and ShareMe for your professionalism and ease of adaptation to Moehs.
At Moehs we continue innovating with the latest technologies, robotising our manufacturing processes. More safety, traceability and efficiency. That is why we are leaders in the production of active ingredients for the pharmaceutical sector.
At Moehs we continue innovating to offer the best service to our customers. Recently, we have increased the production capacity of our Moehs BCN site with new reactors without stopping production at any time, which has continued at full capacity. Our thanks to the engineering, maintenance and management team.
At Moehs we encourage and promote the talent of new students! During these months, we received the visit of 110 students of FP Dual who study at the Institute of ROMANICA (Barberà del Vallès – BCN), belonging to the grades: Certificate of Higher Education in the manufacture of pharmaceutical, biotechnological and related products. Certificate of …
We honor all women and especially those who are part of Moehs. We are always committed to equality in the workplace regardless of gender. We thank them for their professional dedication and daily dedication in all areas.
We are very pleased to show you the work our company Moehs Group Research Center is doing since September 2017 with its integrated development strategy and lifecycle model.
Moehs Group has recently incorporated to its capabilities a GMP compliant Kilo Lab Unit for the development and commercial production of High Potent APIs (HPAPIs). This unit involves 2 isolators with a containment level down to 0,1 µg/m3 OEL. Two reactors, two Nutsche filters and a tray dryer are the main equipment of this unit …
Operative and fully qualified since 2019, the Kilo Lab was successfully inspected by the Spanish Health Agency that granted us the GMP certificate of this facility. The GMP Kilo Lab is located in the Moehs Group Research Center and it is equipped with two 30 l reactors, one centrifuge, one tray drier and a multipurpose …
We are proud to share that last September 15th, the mayor of Polinya Javier Silva and the director of economic promotion Tania Bravo visited our manufacturing site COPRIMA. The managers of the site showed them our facility with special attention to our 1300 m² production plant. Thanks to the authorities of Ajuntament de Polinyà for being close to Coprima.
